Classer les publications sur l'année
-
Pharmaco-Epidémiologie
Mepolizumab in a population with severe osinophilic asthma and corticosteroid dependence: results from French early access programme
TAILLE C, CHANEZ P, DEVOUASSOUX G, DIDIER A, PISON C, GARCIA G, CHARRIOT J, BOUEE S, GRUBER A, PRIBIL C, BOURDIN A, HUMBERT M.
Eur Respir J ; 2020;55(6)
-
Pharmaco-Epidémiologie
Treatment sequence of first and second generation tyrosine kinase inhibitor followed by osimertinib in EGFR-mutated non-small-cell lung cancer: a real life study
GIRARD N, MORO-SIBILOT D, BOUEE S, EMERY C, TORRETON E, LE LAY K, LUCIANI L, MARITAZ C, CHOUAID C.
Future Oncol ; 2020;16(16),1115-1124
-
Biométrie et Analyses de bases de données/SNDS
Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis.
EMERY C, TORRETON E, BRIERE JB, THOMAS EVERS T, FAGNANI F.
J Med Econ ; 2020;23(5):513-520
-
AutresSanté publique
The management of emergency hospital visits for inflammatorybowel diseases: A French national expert consensus report
HEBUTERNE X, PEYRIN-BIROULET L, HAUSFATER P.
Therapie ; 2020;52(4),420-426
-
Autres
Télésurveillance et expérimentations ETAPES. Quelle pérennité aprÚs 2021 : quel modÚle organisationnel et financement ?
LE DOUARIN Y, TRAVERSINO Y, GRACIET A, JOSSERAN A, ET LES PARTICIPANTS DE LA TABLE RONDE « SANTE ET ECONOMIE » DES ATELIERS DE GIENS XXXV, BRIAC BILI A, BLAISE L, CHATELLIER G, COULONJOU H, DELVAL C, DETOURNAY B, DURAND ZALESKI I, FOREST J, DAIDANI N, VANDENBERGUE J.
Therapies ; 2020;75(1),29-42
-
Santé publique
The management of emergency hospital visits for inflammatorybowel diseases: A French national expert consensus report.
HEBUTERNE X, PEYRIN-BIROULET L, HAUSFATER P.
Digestive and Liver Disease ; 2019
-
Ăconomie de la santĂ©
Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: Results of a French multicenter prospective study
HEQUET D, HUCHON C, SOILLY AL, ASSELAIN B, BERSENEFF H, TRICHOT C, COMBES A, ALVES K, NGUYEN T, ROUZIER R, BAFFERT S.
PLoS One ; 2019;14(7)
-
Santé publique
Exposure of adults to extremely low frequency magnetic field in France: results of the EXPERS study.
MAGNE I, SOUQUES M, COUROUVE L, DUBURCQ A, REMY E, CABANES PA.
Radioprotection ; 2020;55(1),39-50
-
Biométrie et Analyses de bases de données/SNDS
The Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database
BOURDIN A, FABRY-VENDRAND C, OSTINELLI J, AIT-YAHIA M, DARNAL E, BOUEE S, LAURENDEAU C, BUREAU I, GOURMELEN J, CHOUAID C.
J Allergy Clin Immunol Pract ; 2019;7(5):1477-1487
-
Pharmaco-Epidémiologie
Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study
DINH A, LE MONNIER A, EMERY C, ALAMI S, TORRETON Ă, DUBURCQ A, BARBIER F.
Eur J Clin Microbiol Infect Dis ; 2019;38(7):1297-1305
-
Biométrie et Analyses de bases de données/SNDS
Migraine burden and costs in france: a nationwide claims database analysis of triptan users.
DONNET A, EMERY C, ALY S, ALLAF B, CAYRE F, MAHIEU N, GOURMELEN J, LEVY P, FAGNANI F.
J Med Econ ; 2019;22(7):616-624
-
Biométrie et Analyses de bases de données/SNDS
Economic burden of chemotherapy-treated recurrent and/or metastatic squamous cell carcinoma of the head and neck in france: real world data from the permanent sample of national health insurance beneficiairies.
LAFUMA A, COTTĂ FE, LE TOURNEAU C, EMERY C, GAUDIN AF, TORRETON E, GOURMELEN J, BONASTRE J.
J Med Econ ; 2019;22(7):698-705
-
Biométrie et Analyses de bases de données/SNDS
Factors associated with parathyroid hormone control in haemodialysis patients with secondary hyperparathyroidism treated with cinacalcet in real-world clinical practice : Mimosa study
ROTTEMBOURG J, URENA-TORRES P, TOLEDANO D, GUEUTIN V, HAMANI A, COLDEFY O, HEBIBI H, GUINCESTRE T, EMERY C.
Clinical Kidney Journal ; 2019;12(6):871-879
-
Santé publique
Remote Monitoring of Diabetes: A Cloud-Connected Digital System for Individuals With Diabetes and Their Health Care Providers.
JOUBERT M, BENHAMOU PY, SCHAEPELYNCK P, HANAIRE H, CATARGI B, FARRET A, FONTAINE P, GUERCI B, REZNIK Y, NATHALIE JEANDIDIER N, PENFORNIS A, BOROT S, CHAILLOUS L, FRANC S, SERUSCLAT P, KHERBACHI Y, BAVIERE E, DETOURNAY B, SIMON P, CHARPENTIER G.
J Diabetes Sci Technol ; 2019;13(6):1161-1168
-
Ăconomie de la santĂ©
Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial results.
HOOGENDOORN M, CORRO RAMOS I, BALDWIN M, LUCIANI L, FABRON C, DETOURNAY B, PMH RUTTEN-VAN MĂLKEN M.
Int J Chron Obstruct Pulmon Dis ; 2019;14:447-456